FTC Targets Amgen Bundling And Rebates In Suit To Block Horizon Acquisition

Complaint marks first time agency has raised novel theories of competitive harm in pharma merger and is rare instance in which it has filed a complaint without a consent decree. Last time FTC has gone to court to block a pharma merger was in 2008.